|
Volumn 63, Issue 15, 2003, Pages 1609-
|
Tenofovir disoproxil fumarate: A viewpoint
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ADEFOVIR;
AMPRENAVIR;
DELAVIRDINE;
DIDANOSINE;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
STAVUDINE;
TENOFOVIR DISOPROXIL;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
TENOFOVIR;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
CYTOTOXICITY;
DIARRHEA;
DISEASE SEVERITY;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
FLATULENCE;
GASTROINTESTINAL DISEASE;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IN VITRO STUDY;
NAUSEA;
NEPHROTOXICITY;
NOTE;
RISK ASSESSMENT;
TREATMENT OUTCOME;
VOMITING;
ANALOGS AND DERIVATIVES;
ANTIVIRAL RESISTANCE;
CHEMICALLY INDUCED;
DRUG EFFECTS;
DRUG POTENTIATION;
HIV INFECTIONS;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
ADENINE;
ANTI-HIV AGENTS;
DRUG RESISTANCE, VIRAL;
DRUG SYNERGISM;
GASTROINTESTINAL DISEASES;
HIV INFECTIONS;
HIV-1;
HUMANS;
ORGANOPHOSPHONATES;
ORGANOPHOSPHORUS COMPOUNDS;
TENOFOVIR;
|
EID: 0043124519
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-200363150-00007 Document Type: Note |
Times cited : (3)
|
References (0)
|